UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 227

Sortiert nach

An In-Home Advanced Robotic System to Manage Elderly Home-Care Patients’ Medications: A Pilot Safety and Usability Study

Clinical therapeutics, 2017-05, Vol.39 (5), p.1054-1061

2017

Link zum Volltext

Verfügbarkeit prüfen

National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA

BMC health services research, 2022-07, Vol.22 (1), p.1-940, Article 940

2022

Link zum Volltext

Verfügbarkeit prüfen

Price and Value: The Pharmacoeconomics of Scarcity

Clinical therapeutics, 2012-02, Vol.34 (2), p.432-433

2012

Link zum Volltext

Verfügbarkeit prüfen

National Versus International Generalizations from Cost-Effectiveness Analyses

Clinical therapeutics, 2011-10, Vol.33 (10), p.1444-1445

2011

Link zum Volltext

Verfügbarkeit prüfen

Judith A. Shinogle, PhD, MSc

Clinical therapeutics, 2012-07, Vol.34 (7), p.1530-1530

Lyles, Alan, ScD, MPH, RPh

2012

Link zum Volltext

Verfügbarkeit prüfen

The Importance of Context to the Generalizability of International Research: The Other Health Care Reform

Clinical therapeutics, 2010-12, Vol.32 (14), p.2442-2443

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?

PharmacoEconomics, 2017-05, Vol.35 (5), p.493-500

Lyles, Alan

2017

Link zum Volltext

Verfügbarkeit prüfen

Systematic reviews: When the published literature is the data

Clinical therapeutics, 2010-09, Vol.32 (10), p.1754-1755

2010

Link zum Volltext

Verfügbarkeit prüfen

The Relevance of International Studies to Informed Pharmacoeconomics and Health Policy Decisions

Clinical therapeutics, 2010, Vol.32 (1), p.106-107

2010

Link zum Volltext

Verfügbarkeit prüfen

Market failures, rational choice, and pharmaceutical economics: The role of empiric information

Clinical therapeutics, 2009-10, Vol.31 (10), p.2150-2151

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness research: NICE for the NHS, but false starts for the US

Clinical therapeutics, 2008-09, Vol.30 (9), p.1702-1703

2008

Link zum Volltext

Verfügbarkeit prüfen

Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses

Clinical therapeutics, 2009, Vol.31 (1), p.192-193

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmaceutical Public Policy

1, 2016

Link zum Volltext

Verfügbarkeit prüfen

The prescribing continuum: Between prescription and over-the-counter drugs

Clinical therapeutics, 2007-10, Vol.29 (10), p.2244-2245

2007

Link zum Volltext

Verfügbarkeit prüfen

Muted Incentives, Omitted Variables, and Pharmacoeconomic Validity: Two Strikes and You're Out

Clinical therapeutics, 2011, Vol.33 (1), p.60-61

2011

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer's disease: The specter of fragmented policy and financing

Clinical therapeutics, 2008, Vol.30 (1), p.192-194

2008

Link zum Volltext

Verfügbarkeit prüfen

Influenza Chemoprophylaxis: The Relative Utility of Number Needed to Treat and Cost-Effectiveness Analyses

Clinical therapeutics, 2007-08, Vol.29 (8), p.1577-1578

2007

Link zum Volltext

Verfügbarkeit prüfen

Health care reform: Is the process the outcome?

Clinical therapeutics, 2009-09, Vol.31 (9), p.2014-2017

2009

Link zum Volltext

Verfügbarkeit prüfen

P-VALUES, EVIDENCE, AND DECISIONS: THERE IS NO EASY BUTTON A COMMENTARY ON “SCIENCE V. SIGNIFICANCE?”

Public administration quarterly, 2019-07, Vol.43 (2), p.222-228

LYLES, ALAN

2019

Link zum Volltext

Verfügbarkeit prüfen

Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics

BMC geriatrics, 2014-11, Vol.14 (1), p.121-121, Article 121

2014

Link zum Volltext

Verfügbarkeit prüfen

Eroding Precision in Scientific Communications: Contagion from “The Real World”

Clinical therapeutics, 2007, Vol.29 (1), p.182-182

2007

Link zum Volltext

Verfügbarkeit prüfen

Obesity, Business and Public Policy

1, 2007

Link zum Volltext

Verfügbarkeit prüfen

Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

Clinical therapeutics, 2007-09, Vol.29 (9), p.2094-2095

2007

Link zum Volltext

Verfügbarkeit prüfen

The Presidential candidates' health care reform platforms: Different principles but few details

Clinical therapeutics, 2008-10, Vol.30 (10), p.1890-1892

2008

Link zum Volltext

Verfügbarkeit prüfen

State of the European Union’s early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020–2022)

Journal of pharmaceutical policy and practice, 2023-11, Vol.16 (1), p.1-135, Article 135

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 227

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Englisch
(227)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An In-Home Advanced Robotic System to Manage Elderly Home-Care Patients’ Medications: A Pilot Safety and Usability Study

National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA

Price and Value: The Pharmacoeconomics of Scarcity

National Versus International Generalizations from Cost-Effectiveness Analyses

Judith A. Shinogle, PhD, MSc

The Importance of Context to the Generalizability of International Research: The Other Health Care Reform

Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?

Systematic reviews: When the published literature is the data

The Relevance of International Studies to Informed Pharmacoeconomics and Health Policy Decisions

Market failures, rational choice, and pharmaceutical economics: The role of empiric information

Comparative effectiveness research: NICE for the NHS, but false starts for the US

Adapting pharmacoeconomic data and methods to extend the postpublication utility of analyses

Pharmaceutical Public Policy

The prescribing continuum: Between prescription and over-the-counter drugs

Muted Incentives, Omitted Variables, and Pharmacoeconomic Validity: Two Strikes and You're Out

Alzheimer's disease: The specter of fragmented policy and financing

Influenza Chemoprophylaxis: The Relative Utility of Number Needed to Treat and Cost-Effectiveness Analyses

Health care reform: Is the process the outcome?

P-VALUES, EVIDENCE, AND DECISIONS: THERE IS NO EASY BUTTON A COMMENTARY ON “SCIENCE V. SIGNIFICANCE?”

Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics

Eroding Precision in Scientific Communications: Contagion from “The Real World”

Obesity, Business and Public Policy

Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?

The Presidential candidates' health care reform platforms: Different principles but few details

State of the European Union’s early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020–2022)

Suchergebnisse filtern